ES306848A1 - Un metodo de producir un 3-ceto-4,6-bisdehidro 9 beta,10 alfa-esteroide. - Google Patents
Un metodo de producir un 3-ceto-4,6-bisdehidro 9 beta,10 alfa-esteroide.Info
- Publication number
- ES306848A1 ES306848A1 ES0306848A ES306848A ES306848A1 ES 306848 A1 ES306848 A1 ES 306848A1 ES 0306848 A ES0306848 A ES 0306848A ES 306848 A ES306848 A ES 306848A ES 306848 A1 ES306848 A1 ES 306848A1
- Authority
- ES
- Spain
- Prior art keywords
- bisdehydro
- beta
- alpha
- translation
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 2
- 150000003431 steroids Chemical class 0.000 abstract 4
- 238000006036 Oppenauer oxidation reaction Methods 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL63301566A NL146503B (nl) | 1963-12-09 | 1963-12-09 | Werkwijze voor de bereiding van een 9beta, 10alfa-pregna-4,6-dieen-3,20-dion. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES306848A1 true ES306848A1 (es) | 1965-05-16 |
Family
ID=19755277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES0306848A Expired ES306848A1 (es) | 1963-12-09 | 1964-12-07 | Un metodo de producir un 3-ceto-4,6-bisdehidro 9 beta,10 alfa-esteroide. |
Country Status (12)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107531746B8 (zh) * | 2015-04-02 | 2023-11-10 | 台州市海盛制药有限公司 | 9β,10α-孕甾-4,6-二烯-3,20-二酮的制备方法 |
| CN110790808B (zh) * | 2019-11-19 | 2022-10-28 | 湖南新合新生物医药有限公司 | 一种5,7-孕甾二烯-3,20-二酮-二乙二缩酮的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL112521C (US08124317-20120228-C00026.png) * | 1960-05-30 |
-
1963
- 1963-12-09 NL NL63301566A patent/NL146503B/xx not_active IP Right Cessation
-
1964
- 1964-12-04 BR BR165078/64A patent/BR6465078D0/pt unknown
- 1964-12-05 DK DK599464AA patent/DK118818B/da unknown
- 1964-12-07 CH CH1586264A patent/CH491898A/de not_active IP Right Cessation
- 1964-12-07 SE SE14769/64A patent/SE335336B/xx unknown
- 1964-12-07 DE DE1468427A patent/DE1468427C3/de not_active Expired
- 1964-12-07 FI FI2578/64A patent/FI42326B/fi active
- 1964-12-07 AT AT1033564A patent/AT266336B/de active
- 1964-12-07 ES ES0306848A patent/ES306848A1/es not_active Expired
- 1964-12-08 US US416744A patent/US3364205A/en not_active Expired - Lifetime
- 1964-12-08 CS CS6877A patent/CS150524B2/cs unknown
- 1964-12-09 GB GB50106/64A patent/GB1096958A/en not_active Expired
- 1964-12-09 GB GB40034/67A patent/GB1096959A/en not_active Expired
-
1966
- 1966-12-07 SE SE12855/66A patent/SE330532B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US3364205A (en) | 1968-01-16 |
| DE1468427C3 (de) | 1974-05-02 |
| BR6465078D0 (pt) | 1973-08-02 |
| NL146503B (nl) | 1975-07-15 |
| GB1096959A (en) | 1967-12-29 |
| AT266336B (de) | 1968-11-11 |
| DE1468427A1 (de) | 1970-01-08 |
| DE1468427B2 (de) | 1973-09-27 |
| GB1096958A (en) | 1967-12-29 |
| DK118818B (da) | 1970-10-12 |
| FI42326B (US08124317-20120228-C00026.png) | 1970-03-31 |
| SE330532B (US08124317-20120228-C00026.png) | 1970-11-23 |
| SE335336B (US08124317-20120228-C00026.png) | 1971-05-24 |
| CS150524B2 (US08124317-20120228-C00026.png) | 1973-09-04 |
| CH491898A (de) | 1970-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES306848A1 (es) | Un metodo de producir un 3-ceto-4,6-bisdehidro 9 beta,10 alfa-esteroide. | |
| ES277297A1 (es) | Procedimiento para preparar margarina | |
| ES304443A1 (es) | Procedimiento para la produccion de clorotrifluoroetilo. | |
| AT264021B (de) | Verfahren zur Herstellung von neuen, in 21-Stellung doppelt veresterten Steroiden | |
| ES315869A1 (es) | Un metodo de producir 3-ceto-4, 6-bisdehidro-6-fluoro-9 beta, 10 alfa-esteroides | |
| CA670370A (en) | METHOD OF PRODUCING 3-KETO- 4, 6, 10 (.alpha.) METHYL STEROIDS | |
| ES288343A1 (es) | Procedimiento para la deshidrogenación de esteroides | |
| ES294357A1 (es) | Procedimiento para la obtención de nuevos nonapepturos | |
| ES276364A1 (es) | Procedimiento de preparación del 3-oxo-17-beta-hidroxi 5-(10)-estreno | |
| AU272278B2 (en) | IMPROVEMENTS IN OR RELATING TO NEW 10a METHYL, 98 STEROIDS AND METHOD OF PRODUCING SAME | |
| ES277176A1 (es) | Procedimiento de preparación de la 18,19-dinor 13 beta n-propil 17 alfa-etinil testosterona | |
| CA632240A (en) | Method of producing slag in particulate form | |
| AU1767962A (en) | IMPROVEMENTS IN OR RELATING TO NEW 10a METHYL, 98 STEROIDS AND METHOD OF PRODUCING SAME | |
| CA675141A (en) | Composition of matter for slowing down and reflecting neutrons, and process of making same | |
| CA661389A (en) | 6.alpha.: 16-DIMETHYLPREGNA-4:16-DIEN-3:20-DIONE AND PROCESS FOR ITS PREPARATION | |
| AU284652B2 (en) | PRODUCTION OF ESTRONE AND 17a SUBSTITUTED ESTERADIOLS | |
| ES268693A3 (es) | Procedimiento para la obtenciën de cuerpos laminares a base de superposiciën de tejidos | |
| ES285050A1 (es) | Procedimiento para la producción de esteroides | |
| ES313454A2 (es) | Procedimiento de preparacion de un esteroide dienico 11-oxigenado. | |
| AU246217B2 (en) | Process for treating refuse and for producing steam therefrom | |
| AU269393B2 (en) | 17a, 21 SUBSTITUTES METHYLENEDIOXY STEROIDS AND PROCESS THEREFOR | |
| ES297137A1 (es) | Procedimiento para la preparacion de 17 alfa-etoxi-6-cloro-6-dehidro-progesterona | |
| ES295478A1 (es) | Procedimiento para la preparacion de 17alfa-alcoxi-esteroides | |
| ES308471A1 (es) | Un procedimiento de preparacion del 3, 16 beta-dihidroxi 16 alfaetinil 19-nor 1, 3, 5 (10) -androstatrieno | |
| ES263915A3 (es) | Procedimiento de obtenciën de hormonas y vitaminas, en especial b 12 de efecto lento por via inyectable |